When my first son, Tom, was born I joked (bitterly) that all I had to do to be a better father than my father had been was to survive for more than four…
Drug developer Depomed Inc announced it would recall 52 lots of its type 2 diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle, according to a Reuters report...
Neurocrine Biosciences, Inc. announcedthat they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of type 2 diabetes. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is...
To me, diabetes acceptance equals defeat. By accepting diabetes as a permanent part of life, I had little energy or even willingness to stay on top of it...
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. announced results from DURATION-4, the fourth in a series of studies designed to test the superiority of Bydureon (exenatide extended-release for injectable suspension), an investigational type 2 diabetes therapy, as compared to other type 2 diabetes medications...
A new study published in the Annals of Internal Medicine shows hemoglobin A1c levels differ in black and white persons independent of glucose levels.
The study looked at 1581 non-Hispanic black and white persons in the Atlanta area between 18 and 87 years of age who did not have known diabetes...